Prof Amrith Rao (@urorao) 's Twitter Profile
Prof Amrith Rao

@urorao

Robotic Urological Surgeon with Special Interest in Urologic Cancers

ID: 468529910

calendar_today19-01-2012 16:53:27

3,3K Tweet

1,1K Followers

479 Following

UroToday.com (@urotoday) 's Twitter Profile Photo

PSA persistence after radical prostatectomy: Optimal treatment in the case of PSA persistence. Presentation by @profnickjames The ICR. #EAU24 written coverage by Rashid K. Sayyid University of Toronto on UroToday > bit.ly/43UUGnm European Association of Urology (EAU)

PSA persistence after radical prostatectomy: Optimal treatment in the case of PSA persistence. Presentation by @profnickjames <a href="/ICR_London/">The ICR</a>. #EAU24 written coverage by <a href="/RKSayyid/">Rashid K. Sayyid</a> <a href="/UofT/">University of Toronto</a> on UroToday &gt; bit.ly/43UUGnm <a href="/Uroweb/">European Association of Urology (EAU)</a>
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Fantastic meeting of IMG Oncologists (37% of practicing oncologists in USA) steered by Toni Choueiri, MD Ziad Bakouny, MD, MSc Nazli Dizman ๐Ÿ‘‰Challenges faced by IMGs, Insights from the 2023 meeting, how to join the group๐Ÿ‘‡ASCO #ASCO24 #IMGCoP meeting overview ๐Ÿ‘‡OncoAlert #ASCODailyNews

Fantastic meeting of <a href="/IMG_Oncologists/">IMG Oncologists</a> (37% of practicing oncologists in USA) steered by <a href="/DrChoueiri/">Toni Choueiri, MD</a> <a href="/ZiadBakouny/">Ziad Bakouny, MD, MSc</a> <a href="/NazliDizman/">Nazli Dizman</a> ๐Ÿ‘‰Challenges faced by IMGs, Insights from the 2023 meeting, how to join the group๐Ÿ‘‡<a href="/ASCO/">ASCO</a> #ASCO24 #IMGCoP meeting overview ๐Ÿ‘‡<a href="/OncoAlert/">OncoAlert</a> #ASCODailyNews
Roger Li (@urogerlimd) 's Twitter Profile Photo

Final results of #CORE001 trial out now Nature Medicine (1/14) 35 pts with BCG-UR CIS treated w/ Creto + pembro ๐Ÿ‘‰12mo CR (per RBB) = 57.1% (ITT) ๐Ÿ‘‰24mo CR = 54% *(Auth Corr) ๐Ÿ‘‰No patient progressed to MIBC ๐Ÿ‘‰No synergistic toxicity Gary Steinberg nature.com/articles/s4159โ€ฆ

Final results of #CORE001 trial out now <a href="/NatureMedicine/">Nature Medicine</a> (1/14)

35 pts with BCG-UR CIS treated w/ Creto + pembro

๐Ÿ‘‰12mo CR (per RBB) = 57.1% (ITT)
๐Ÿ‘‰24mo CR = 54% *(Auth Corr)
๐Ÿ‘‰No patient progressed to MIBC
๐Ÿ‘‰No synergistic toxicity

<a href="/garysteinbergmd/">Gary Steinberg</a>

nature.com/articles/s4159โ€ฆ
Tom Powles (@tompowles1) 's Twitter Profile Photo

The EMA has approved Enfortumab Vedotin and pembrolizumab for 1st line urothelial cancer. It supersedes 1st platinum based therapy as the new standard of care in Europe. astellas.com/en/news/29371?โ€ฆ

International Chess Federation (@fide_chess) 's Twitter Profile Photo

The 45th #ChessOlympiad officially concluded tonight with the closing ceremony! Congratulations to the winners ๐Ÿ”ฅ Open Section ๐Ÿ‘‡ ๐Ÿฅ‡ India ๐Ÿ‡ฎ๐Ÿ‡ณ ๐Ÿฅˆ United States of America ๐Ÿ‡บ๐Ÿ‡ธ ๐Ÿฅ‰ Uzbekistan ๐Ÿ‡บ๐Ÿ‡ฟ Women's Section ๐Ÿ‘‡ ๐Ÿฅ‡ India ๐Ÿ‡ฎ๐Ÿ‡ณ ๐Ÿฅˆ Kazakhstan ๐Ÿ‡ฐ๐Ÿ‡ฟ ๐Ÿฅ‰ United States of America ๐Ÿ‡บ๐Ÿ‡ธ ๐Ÿงต

The 45th #ChessOlympiad officially concluded tonight with the closing ceremony!

Congratulations to the winners ๐Ÿ”ฅ
Open Section ๐Ÿ‘‡
๐Ÿฅ‡ India ๐Ÿ‡ฎ๐Ÿ‡ณ
๐Ÿฅˆ United States of America ๐Ÿ‡บ๐Ÿ‡ธ
๐Ÿฅ‰ Uzbekistan ๐Ÿ‡บ๐Ÿ‡ฟ

Women's Section ๐Ÿ‘‡
๐Ÿฅ‡ India ๐Ÿ‡ฎ๐Ÿ‡ณ
๐Ÿฅˆ Kazakhstan ๐Ÿ‡ฐ๐Ÿ‡ฟ
๐Ÿฅ‰ United States of America ๐Ÿ‡บ๐Ÿ‡ธ

๐Ÿงต
Axel S. Merseburger (@amerseburger) 's Twitter Profile Photo

Out now and open access ๐Ÿ‘‡: Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naรฏve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study European Association of Urology (EAU) OncoAlert ONCO BRUNO UroToday.com Universitรคtsklinikum Schleswig-Holstein rdcu.be/ebWMr